----

|   | [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------------------------------------------------------------------------------|

|   | [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------------------------------------------------------------------------------------------|

| Delaware                                                       | 06-1150326                        |
|----------------------------------------------------------------|-----------------------------------|
|                                                           |                              |
| (State or other jurisdiction of incorporation or organization) | (IRS employer identification no.) |
|                                                           |                              |

| Two Manhattanville Road                  |       |
|------------------------------------------|------------|
|                                     |       |
| Purchase, NY                             | 10577      |
|                                     |       |
| (Address of principal executive offices) | (Zip code) |

| Large Accelerated filer   ̈ | Accelerated Filer  x              |
|-------------------------------------------|---------------------------------------------|
|                                      |                                        |
| Non-Accelerated filer   ̈   | Smaller Reporting Company   ̈ |
|                                      |                                        |

----

|                                                                                                                   |     |                                                                                                  | Page   |
|------------------------------------------------------------------------------------------------------------------------|----------|-------------------------------------------------------------------------------------------------------|--------|
| PART I.                                                                                                                |     | FINANCIAL INFORMATION                                                                                 |   |
|                                                                                                                   |     |                                                                                                  |   |
| Item 1.                                                                                                                |     | Financial Statements                                                                                  |   |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     | Consolidated Balance Sheets at March 31, 2010 and December 31, 2009                                   | 3      |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     | Consolidated Statements of Operations for the three-month period ended March 31, 2010 and 2009        | 4      |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     | Consolidated Statements of Shareholders’ Equity for the three-month period ended March 31, 2010 | 5      |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     | Consolidated Statements of Cash Flows for the three-month periods ended March 31, 2010 and 2009       | 6      |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     | Notes to Consolidated Financial Statements                                                            | 7-13   |
|                                                                                                                   |     |                                                                                                  |   |
|                                                                                                                   |     |                                                                                                  |   |
| Item 2.                                                                                                                |     | Management’s Discussion and Analysis of Financial Condition and Results of Operations           | 14-23  |
|                                                                                                                   |     |                                                                                                  |   |
| Item 3.                                                                                                                |     | Quantitative and Qualitative Disclosures About Market Risk                                            | 23     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 4.                                                                                                                |     | Controls and Procedures                                                                               | 23-24  |
|                                                                                                                   |     |                                                                                                  |   |
| PART II.                                                                                                               |     | OTHER INFORMATION                                                                                     |   |
|                                                                                                                   |     |                                                                                                  |   |
| Item 1.                                                                                                                |     | Legal Proceedings                                                                                     | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 1A.                                                                                                               |     | Risk Factors                                                                                          | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 2.                                                                                                                |     | Unregistered Sales of Equity Securities and Use of Proceeds                                           | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 3.                                                                                                                |     | Defaults Upon Senior Securities                                                                       | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 4.                                                                                                                |     | Submission of Matters to a Vote of Security Holders                                                   | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 5.                                                                                                                |     | Other Information                                                                                     | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| Item 6.                                                                                                                |     | Exhibits                                                                                              | 25     |
|                                                                                                                   |     |                                                                                                  |   |
| SIGNATURES                                                                                                             | 26       |
|                                                                                                                   |     |                                                                                                  |   |
| CERTIFICATIONS PURSUANT TO RULE 13A-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002        | EXHIBITS |
|                                                                                                                   |     |                                                                                                  |   |
| CERTIFICATIONS PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 | EXHIBITS |

----

|                                                                                                                                                                                                                  |   | March 31,   |    |   | December 31, |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------|---------|--------|--------------|--------|
|                                                                                                                                                                                                                  |   | 2010        |    |   | 2009         |   |
|                                                                                                                                                                                                                  |   | (unaudited) |    |   |         |   |
| ASSETS                                                                                                                                                                                                                |   |        |    |   |         |   |
| Current Assets                                                                                                                                                                                                        |   |        |    |   |         |   |
| Cash and cash equivalents                                                                                                                                                                                             |   | $           | 46,622  |   |         | $      | 28,865 |   |
| Patient and other receivables, net                                                                                                                                                                                    |   |        | 7,447   |   |         |   | 6,964 |   |
| Deferred taxes                                                                                                                                                                                                        |   |        | 3,012   |   |         |   | 2,883 |   |
| Other current assets                                                                                                                                                                                                  |   |        | 10,522  |   |         |   | 7,653 |   |
| Total current assets                                                                                                                                                                                                  |   |        | 67,603  |   |         |   | 46,365 |   |
|                                                                                                                                                                                                                  |   |        |    |   |         |   |   |   |
| Fixed assets, net                                                                                                                                                                                                     |   |        | 17,123  |   |         |   | 16,705 |   |
| Intangible assets, Business Service Rights, net                                                                                                                                                                       |   |        | 23,886  |   |         |   | 24,210 |   |
| Goodwill                                                                                                                                                                                                              |   |        | 30,334  |   |         |   | 30,334 |   |
| Trademarks                                                                                                                                                                                                            |   |        | 4,442   |   |         |   | 4,442 |   |
| Other assets                                                                                                                                                                                                          |   |        | 2,057   |   |         |   | 2,253 |   |
| Total assets                                                                                                                                                                                                          |   | $           | 145,445 |   |         | $      | 124,309 |   |
|                                                                                                                                                                                                                  |   |        |    |   |         |   |   |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                                                                            |   |        |    |   |         |   |   |   |
| Current liabilities                                                                                                                                                                                                   |   |        |    |   |         |   |   |   |
| Accounts payable                                                                                                                                                                                                      |   | $           | 2,436   |   |         | $      | 2,846 |   |
| Accrued liabilities                                                                                                                                                                                                   |   |        | 15,036  |   |         |   | 15,119 |   |
| Current portion of long-term notes payable and other obligations                                                                                                                                                      |   |        | 11,299  |   |         |   | 11,317 |   |
| Due to Fertility Medical Practices                                                                                                                                                                                    |   |        | 7,376   |   |         |   | 6,424 |   |
| Attain IVF deferred revenue and other patient deposits                                                                                                                                                                |   |        | 14,528  |   |         |   | 13,362 |   |
| Total current liabilities                                                                                                                                                                                             |   |        | 50,675  |   |         |   | 49,068 |   |
|                                                                                                                                                                                                                  |   |        |    |   |         |   |   |   |
| Deferred and other tax liabilities                                                                                                                                                                                    |   |        | 2,370   |   |         |   | 2,199 |   |
| Long-term notes payable and other obligations                                                                                                                                                                         |   |        | 13,848  |   |         |   | 14,849 |   |
| Total liabilities                                                                                                                                                                                                     |   |        | 66,893  |   |         |   | 66,116 |   |
|                                                                                                                                                                                                                  |   |        |    |   |         |   |   |   |
| Commitments and Contingencies                                                                                                                                                                                         |   |        |    |   |         |   |   |   |
|                                                                                                                                                                                                                  |   |        |    |   |         |   |   |   |
| Shareholders’ equity:                                                                                                                                                                                           |   |        |    |   |         |   |   |   |
| Common Stock, $.01 par value – 15,000,000 shares authorized on March 31, 2010 and December 31, 2009, respectively, 11,816,486 and 8,831,558 shares issued on March 31, 2010 and December 31, 2009, respectively |   |        | 118     |   |         |   | 88 |   |
| Capital in excess of par                                                                                                                                                                                              |   |        | 75,804  |   |         |   | 56,354 |   |
| Other comprehensive loss                                                                                                                                                                                              |   |        | (124    | )      |         |   | (188 | ) |
| Treasury stock, at cost – 85,018 and 46,408 shares on March 31, 2010 and December 31, 2009, respectively                                                                                                        |   |        | (681    | )      |         |   | (375 | ) |
| Retained earnings                                                                                                                                                                                                     |   |        | 3,435   |   |         |   | 2,314 |   |
| Total shareholders’ equity                                                                                                                                                                                      |   |        | 78,552  |   |         |   | 58,193 |   |
| Total liabilities and shareholders’ equity                                                                                                                                                                      |   | $           | 145,445 |   |         | $      | 124,309 |   |

----

|                                                     |   | For theThree-month periodended March 31, |   |
|----------------------------------------------------------|--------|------------------------------------------|--------|
|                                                     |   | 2010                                     |   |   | 2009 |   |
| Revenues, net                                            |   |                                     |   |   |   |   |
| Fertility Centers                                        |   | $                                        | 37,957 |   |   | $ | 36,283 |   |
| Consumer Services                                        |   |                                     | 6,086  |   |   |   | 5,226 |   |
| Vein Clinics                                             |   |                                     | 12,981 |   |   |   | 10,846 |   |
|  Total revenues                                     |   |                                     | 57,024 |   |   |   | 52,355 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| Costs of services and sales                              |   |                                     |   |   |   |   |   |   |
| Fertility Centers                                        |   |                                     | 34,902 |   |   |   | 33,643 |   |
| Consumer Services                                        |   |                                     | 4,696  |   |   |   | 3,713 |   |
| Vein Clinics                                             |   |                                     | 12,114 |   |   |   | 10,092 |   |
| Total costs of services and sales                        |   |                                     | 51,712 |   |   |   | 47,448 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| Contribution                                             |   |                                     |   |   |   |   |   |   |
| Fertility Centers                                        |   |                                     | 3,055  |   |   |   | 2,640 |   |
| Consumer Services                                        |   |                                     | 1,390  |   |   |   | 1,513 |   |
| Vein Clinics                                             |   |                                     | 867    |   |   |   | 754 |   |
| Total contribution                                       |   |                                     | 5,312  |   |   |   | 4,907 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| General and administrative expenses                      |   |                                     | 3,196  |   |   |   | 3,138 |   |
| Interest income                                          |   |                                     | (73    | ) |   |   | (77 | ) |
| Interest expense                                         |   |                                     | 277    |   |   |   | 297 |   |
| Total other expenses, net                                |   |                                     | 3,400  |   |   |   | 3,358 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| Income before income taxes                               |   |                                     | 1,912  |   |   |   | 1,549 |   |
| Income tax provision                                     |   |                                     | 791    |   |   |   | 629 |   |
| Net income                                               |   | $                                        | 1,121  |   |   | $ | 920 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| Basic and diluted net earnings per share of Common Stock |   |                                     |   |   |   |   |   |   |
| Basic earnings per share                                 |   | $                                        | 0.11   |   |   | $ | 0.10 |   |
| Diluted earnings per share                               |   | $                                        | 0.11   |   |   | $ | 0.10 |   |
|                                                     |   |                                     |   |   |   |   |   |   |
| Weighted average shares – basic                    |   |                                     | 10,217 |   |   |   | 8,762 |   |
| Weighted average shares - diluted                        |   |                                     | 10,269 |   |   |   | 8,827 |   |

----

|                                                         |   | Common Stock |    |   |   |   |    |                    |   |   | Treasury Shares                         |   |   |   |    |   |   |   |
|--------------------------------------------------------------|--------|--------------|---------|--------|--------|--------|---------|-------------------------|--------|--------|-----------------------------------------|--------|--------|--------|---------|--------|--------|--------|
|                                                         |   | Shares       |    |   | Amount |   |    | Capital inExcess of Par |   |   | Accumulated Comprehensive Income (loss) |   |   | Shares |    |   | Amount |   |   | Retained Earnings |   |   | Total Equity |   |
| Balance at December 31, 2009                                 |   |         | 8,832   |   |   | $      | 88      |                    |   | $      | 56,354                                  |   |   | $      | (188    | )      |   |   | 46 |   |   | $ | (375 | ) |   | $ | 2,314 |   |   | $ | 58,193 |   |
| Stock awards granted, net                                    |   |         | 171     |   |   |   | 1       |                    |   |   | (1                                      | )      |   |   | — |   |   |   | 39 |   |   |   | (306 | ) |   |   | — |   |   |   | (306 | ) |
| Restricted stock award and stock option expense amortization |   |         | — |   |   |   | — |                    |   |   | 366                                     |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 366 |   |
| Stock options exercised and related tax benefits             |   |         | 13      |   |   |   | 1       |                    |   |   | 24                                      |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 25 |   |
| Unrealized gain on hedging transaction                       |   |         | — |   |   |   | — |                    |   |   | 26                                      |   |   |   | 64      |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 90 |   |
| Secondary Offering                                           |   |         | 2,800   |   |   |   | 28      |                    |   |   | 19,035                                  |   |   |   | — |   |   |   | — |   |   |   |   |   |   |   | — |   |   |   | 19,063 |   |
| Net income for the three months endedMarch 31, 2010          |   |         | — |   |   |   | — |                    |   |   | —                                 |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 1,121 |   |   |   | 1,121 |   |
|  Balance at March 31, 2010                              |   |         | 11,816  |   |   | $      | 118     |                    |   | $      | 75,804                                  |   |   | $      | (124    | )      |   |   | 85 |   |   | $ | (681 | ) |   | $ | 3,435 |   |   | $ | 78,552 |   |

----

|                                                                                        |   | For the three-month periodended March 31, |   |
|---------------------------------------------------------------------------------------------|--------|-------------------------------------------|--------|
|                                                                                        |   |                                      | 2010   |   |   |   | 2009 |   |
|                                                                                        |   | (unaudited)                               |   |
| Cash flows from operating activities:                                                       |   |                                      |   |   |   |   |   |   |
| Net income                                                                                  |   | $                                         | 1,121  |   |   | $ | 920 |   |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |   |                                      |   |   |   |   |   |   |
| Depreciation and amortization                                                               |   |                                      | 1,676  |   |   |   | 1,803 |   |
| Deferred income tax provision                                                               |   |                                      | 28     |   |   |   | (343 | ) |
| Stock-based compensation                                                                    |   |                                      | 366    |   |   |   | 384 |   |
| Changes in assets and liabilities —                                                   |   |                                      |   |   |   |   |   |   |
| Decrease (increase) in assets                                                               |   |                                      |   |   |   |   |   |   |
| Patient and other accounts receivable                                                       |   |                                      | (483   | ) |   |   | (580 | ) |
| Other current assets                                                                        |   |                                      | (2,869 | ) |   |   | (1,331 | ) |
| Other assets                                                                                |   |                                      | 196    |   |   |   | 165 |   |
| (Decrease) increase in liabilities                                                          |   |                                      |   |   |   |   |   |   |
| Accounts payable                                                                            |   |                                      | (410   | ) |   |   | (1,038 | ) |
| Accrued liabilities                                                                         |   |                                      | (389   | ) |   |   | (1,515 | ) |
| Due to fertility medical practices                                                          |   |                                      | 952    |   |   |   | 977 |   |
| Attain IVF deferred revenue and other patient deposits                                      |   |                                      | 1,166  |   |   |   | (25 | ) |
| Net cash provided by (used in) operating activities                                         |   |                                      | 1,354  |   |   |   | (583 | ) |
|                                                                                        |   |                                      |   |   |   |   |   |   |
| Cash flows from investing activities:                                                       |   |                                      |   |   |   |   |   |   |
| Purchase of fixed assets, net                                                               |   |                                      | (1,770 | ) |   |   | (2,566 | ) |
| Net cash used in investing activities                                                       |   |                                      | (1,770 | ) |   |   | (2,566 | ) |
|                                                                                        |   |                                      |   |   |   |   |   |   |
| Cash flows from financing activities:                                                       |   |                                      |   |   |   |   |   |   |
| Debt repayments, net                                                                        |   |                                      | (915   | ) |   |   | (913 | ) |
| Common Stock transactions, net                                                              |   |                                      | 19,088 |   |   |   | (164 | ) |
| Net cash provided by (used in) financing activities                                         |   |                                      | 18,173 |   |   |   | (1,077 | ) |
|                                                                                        |   |                                      |   |   |   |   |   |   |
| Net increase (decrease) in cash and cash equivalents                                        |   |                                      | 17,757 |   |   |   | (4,226 | ) |
| Cash and cash equivalents at beginning of period                                            |   |                                      | 28,865 |   |   |   | 28,275 |   |
| Cash and cash equivalents at end of period                                                  |   | $                                         | 46,622 |   |   | $ | 24,049 |   |
|                                                                                        |   |                                      |   |   |   |   |   |   |
| Supplemental Information:                                                                   |   |                                      |   |   |   |   |   |   |
| Interest paid                                                                               |   | $                                         | 321    |   |   | $ | 297 |   |
| Income taxes paid                                                                           |   | $                                         | 362    |   |   | $ | 2,663 |   |

----

|                                                                   |   | For the three-month periodEnded March 31,, |   |
|------------------------------------------------------------------------|--------|--------------------------------------------|--------|
|                                                                   |   | 2010                                       |   |   | 2009 |   |
| Numerator                                                              |   |                                       |   |   |   |   |
|  Net Income                                                       |   | $                                          | 1,121  |   |   | $ | 920 |   |
|                                                                   |   |                                       |   |   |   |   |   |   |
| Denominator                                                            |   |                                       |   |   |   |   |   |   |
| Weighted average shares outstanding (basic)                            |   |                                       | 10,217 |   |   |   | 8,762 |   |
| Effect of dilutive options and warrants                                |   |                                       | 52     |   |   |   | 65 |   |
| Weighted average shares and dilutive potential Common shares (diluted) |   |                                       | 10,269 |   |   |   | 8,827 |   |
|                                                                   |   |                                       |   |   |   |   |   |   |
| Basic earnings per share                                               |   | $                                          | 0.11   |   |   | $ | 0.10 |   |
| Diluted earnings per share                                             |   | $                                          | 0.11   |   |   | $ | 0.10 |   |

----

|                                      |   | Fertility Centers |    |   | Consumer Services |   |    | VeinClinics |   |   | Corp G&A |   |   | Consolidated |    |
|-------------------------------------------|--------|-------------------|---------|--------|-------------------|--------|---------|-------------|--------|--------|--------------|--------|--------|--------------|---------|
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |
| For the three months ended March 31, 2010 |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |
| Total Revenues, net                       |   | $                 | 37,957  |   |              | $      | 6,086   |        |   | $      | 12,981       |   |   | $            | — |   |   | $ | 57,024 |   |
| Cost of Services and Sales                |   |              | 34,902  |   |              |   | 4,696   |        |   |   | 12,114       |   |   |         | — |   |   |   | 51,712 |   |
| Contribution                              |   |              | 3,055   |   |              |   | 1,390   |        |   |   | 867          |   |   |         | — |   |   |   | 5,312 |   |
| Operating margin                          |   |              | 8.0     | %      |              |   | 22.8    | %           |   |   | 6.7          | %      |   |         | 0.0     | % |   |   | 9.3 | % |
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| General and Administrative                |   |              | — |   |              |   | — |        |   |   | —      |   |   |         | 3,196   |   |   |   | 3,196 |   |
| Interest, net                             |   |              | (73     | )      |              |   | — |        |   |   | —      |   |   |         | 277     |   |   |   | 204 |   |
| Income before income taxes                |   | $                 | 3,128   |   |              | $      | 1,390   |        |   | $      | 867          |   |   | $            | (3,473  | ) |   | $ | 1,912 |   |
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| Depreciation expense included above       |   | $                 | 961     |   |              | $      | — |        |   | $      | 236          |   |   | $            | 173     |   |   | $ | 1,370 |   |
| Capital Expenditures                      |   | $                 | 1,146   |   |              | $      | — |        |   | $      | 547          |   |   | $            | 77      |   |   | $ | 1,770 |   |
| Total Assets                              |   | $                 | 39,497  |   |              | $      | 84      |        |   | $      | 52,731       |   |   | $            | 53,133  |   |   | $ | 145,445 |   |
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| For the three months ended March 31, 2009 |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| Total Revenues, net                       |   | $                 | 36,283  |   |              | $      | 5,226   |        |   | $      | 10,846       |   |   | $            | — |   |   | $ | 52,355 |   |
| Cost of Services and Sales                |   |              | 33,643  |   |              |   | 3,713   |        |   |   | 10,092       |   |   |         | — |   |   |   | 47,448 |   |
| Contribution                              |   |              | 2,640   |   |              |   | 1,513   |        |   |   | 754          |   |   |         | — |   |   |   | 4,907 |   |
| Operating margin                          |   |              | 7.3     | %      |              |   | 29.0    | %           |   |   | 7.0          | %      |   |         | 0.0     | % |   |   | 9.4 | % |
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| General and Administrative                |   |              | — |   |              |   | — |        |   |   | —      |   |   |         | 3,138   |   |   |   | 3,138 |   |
| Interest, net                             |   |              | (34     | )      |              |   | — |        |   |   | —      |   |   |         | 254     |   |   |   | 220 |   |
| Income before income taxes                |   | $                 | 2,674   |   |              | $      | 1,513   |        |   | $      | 754          |   |   | $            | (3,392  | ) |   | $ | 1,549 |   |
|                                      |   |              |    |   |              |   |    |        |   |   |         |   |   |         |    |   |   |   |   |   |
| Depreciation expense included above       |   | $                 | 1,058   |   |              |   |    |        |   | $      | 205          |   |   | $            | 216     |   |   | $ | 1,479 |   |
| Capital Expenditures                      |   | $                 | 2,221   |   |              |   |    |        |   | $      | 163          |   |   | $            | 182     |   |   | $ | 2,566 |   |
| Total Assets                              |   | $                 | 37,877  |   |              | $      | 630     |        |   | $      | 48,873       |   |   | $            | 32,235  |   |   | $ | 119,615 |   |

|                            |  March 31, |          | December 31, |    |
|---------------------------------|-----------------|---------------|--------------|---------|
|                            |  2010      |          | 2009         |    |
|                            |            | (unaudited)   |         |    |   |
|  Cash                      | $               | 33,525        |         | $       | 15,770 |   |
| Short term investments          |            | 13,097        |         |    | 13,081 |   |
| Accrued interest income         |            |  — |         |    |  14 |   |
| Total cash and cash equivalents |  $         |  46,622  |         |  $ |  28,865 |   |

----

|                                          |   | March 31,   |   |   | December 31, |   |
|-----------------------------------------------|--------|-------------|--------|--------|--------------|--------|
|                                          |   | 2010        |   |   | 2009         |   |
|                                          |   | (unaudited) |   |   |         |   |
| Vein Clinic patient and insurance receivables |   | $           | 14,599 |   |         | $      | 13,073 |   |
| Reserve for insurance contractual allowance   |   |        | (4,006 | )      |         |   | (3,300 | ) |
| Reserve for uncollectible accounts            |   |        | (3,230 | )      |         |   | (2,913 | ) |
| Subtotal Vein Clinic receivables, net         |   |        | 7,363  |   |         |   | 6,860 |   |
| Other receivables                             |   |        | 84     |   |         |   | 104 |   |
| Total Patient and other receivables, net      |   | $           | 7,447  |   |         | $      | 6,964 |   |

----

|                                    | March 31,   |   | December 31, |   |
|-----------------------------------------|-------------|--------|--------------|--------|
|                                    | 2010        |   | 2009         |   |
|                                    | (unaudited) |   |         |   |
| Advances to Medical Practices           |        | $      | (16,619      | )      |   | $ | (14,653 | ) |
| Undistributed Physician Earnings        |        |   | 1,969        |   |   |   | 2,270 |   |
| Physician Practice Patient Deposits     |        |   | 22,026       |   |   |   | 18,807 |   |
| Due to Fertility Medical Practices, net |        | $      | 7,376        |   |   | $ | 6,424 |   |

|                                          |   | March 31,   |    |   | December 31, |   |
|-----------------------------------------------|--------|-------------|---------|--------|--------------|--------|
|                                          |   | 2010        |    |   | 2009         |   |
|                                          |   | (unaudited) |    |   |         |   |
| Term Loans                                    |   | $           | 17,250  |   |         | $      | 18,142 |   |
| Revolving Line of Credit                      |   |        | 7,500   |   |         |   | 7,500 |   |
| Derivative Fair valuation adjustment          |   |        | 201     |   |         |   | 306 |   |
| Obligations under capital lease               |   |        | 196     |   |         |   | 218 |   |
|                                          |   |        |    |   |         |   |   |   |
| Total notes payable and other obligations     |   | $           | 25,147  |   |         | $      | 26,166 |   |
| Less — current portion                  |   |        | (11,299 | )      |         |   | (11,317 | ) |
|                                          |   |        |    |   |         |   |   |   |
| Long-term notes payable and other obligations |   | $           | 13,848  |   |         | $      | 14,849 |   |

----

|                          |   | For the three-month periodEnded March 31, |
|-------------------------------|--------|-------------------------------------------|
|                          |   | 2010                                      |   | 2009 |
| Fair value of options granted |   | $                                         | 5.13 |   | N/A |
| Dividend yield                |   |                                      | 0 | % | N/A |
| Expected volatility           |   |                                      | 58.2 | % | N/A |
| Risk free interest rate       |   |                                      | 4.0 | % | N/A |
| Expected term in years        |   |                                      | 5.0 |   | N/A |

|                                     |  Number of shares of Common Stock underlying options |   | Weighted Average Exercise Price |   |
|------------------------------------------|-----------------------------------------------------------|--------|---------------------------------|--------|
| Options outstanding at December 31, 2009 | 205,685                                                   |   | $                               | 5.78   |   |
| Granted – stock options            | 74,000                                                    |   |                            | 7.95   |   |
| Granted – stock awards             | 154,171                                                   |   |                            | 7.95   |   |
| Exercised – stock options          | 13,535                                                    |   | $                               | 1.80   |   |
| Exercised – stock awards           | 154,171                                                   |   |                            | 7.95   |   |
| Canceled                                 | -                                                         |   |                            |   |   |
|                                     |                                                      |   |                            |   |   |
| Options outstanding at March 31, 2010    | 266,150                                                   |   | $                               | 6.91   |   |
|                                     |                                                      |   |                            |   |   |
| Options exercisable at:                  |                                                      |   |                            |   |   |
| December 31, 2009                        | 119,771                                                   |   | $                               | 4.64   |   |
| March 31, 2010                           | 114,225                                                   |   | $                               | 5.24   |   |

----

|                                          |   | For the three-month periodended March 31, |   |
|-----------------------------------------------|--------|-------------------------------------------|--------|
|                                          |   | 2010                                      |   |   | 2009 |   |
| Net income as reported                        |   | $                                         | 1,121  |   |   | $ | 920 |   |
| Unrealized gain (loss) on hedging transaction |   |                                      | 64     |   |   |   | 50 |   |
|                                          |   |                                      |   |   |   |   |   |   |
| Total comprehensive income                    |   | $                                         | 1,185  |   |   | $ | 970 |   |

----

----

|          |                                                                 |
|---------------|----------------------------------------------------------------------|
| •  | Making selective contract acquisitions of Partner fertility centers; |
|          |                                                                 |
| •  | Expanding our network of Affiliate fertility centers;                |
|          |                                                                 |
| •  | Developing de novo vein clinics;                                     |
|          |                                                                 |
| •  | Increasing the total number of patients treated;                     |
|          |                                                                 |
| •  | Increasing the penetration of our Attain IVF programs; and      |
|          |                                                                 |
| •  | Continuing to improve operating efficiencies.                        |

----

----

|                                |   | For the three-month periodEnded March 31, |   |
|-------------------------------------|--------|-------------------------------------------|--------|
|                                |   | 2010                                      |   | 2009 |   |
| Revenues, Net                       |   |                                      |   |   |   |   |
| Fertility Centers                   |   |                                      | 66.5   | % | 69.3 | % |
| Consumer Services                   |   |                                      | 10.7   | % | 10.0 | % |
| Vein Clinics                        |   |                                      | 22.8   | % | 20.7 | % |
| Total revenues                      |   |                                      | 100.0  | % | 100.0 | % |
|                                |   |                                      |   |   |   |   |
| Cost of services and sales          |   |                                      |   |   |   |   |
| Fertility Centers                   |   |                                      | 61.2   | % | 64.3 | % |
| Consumer Services                   |   |                                      | 8.2    | % | 7.1 | % |
| Vein Clinics                        |   |                                      | 21.3   | % | 19.3 | % |
| Total cost of services and sales    |   |                                      | 90.7   | % | 90.7 | % |
|                                |   |                                      |   |   |   |   |
| Contribution                        |   |                                      |   |   |   |   |
| Fertility Centers                   |   |                                      | 5.4    | % | 5.0 | % |
| Consumer Services                   |   |                                      | 2.4    | % | 2.9 | % |
| Vein Clinics                        |   |                                      | 1.5    | % | 1.4 | % |
| Total contributions                 |   |                                      | 9.3    | % | 9.4 | % |
|                                |   |                                      |   |   |   |   |
| General and administrative expenses |   |                                      | 5.6    | % | 6.0 | % |
| Interest income                     |   |                                      | (0.1   | )% | (0.1 | )% |
| Interest expense                    |   |                                      | 0.4    | % | 0.4 | % |
| Total other expenses                |   |                                      | 5.9    | % | 6.3 | % |
|                                |   |                                      |   |   |   |   |
| Income before income taxes          |   |                                      | 3.4    | % | 3.0 | % |
| Income tax provision                |   |                                      | 1.4    | % | 1.2 | % |
| Net income                          |   |                                      | 2.0    | % | 1.8 | % |

----

| ·   | A base service fee calculated as a percentage of patient revenue as reported by the center (this percentage varies from 6% down to 3% depending on the agreement and the level of patient revenues); |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Cost of services equal to reimbursement for the expenses which we advanced to the center during the month (representing substantially all of the expenses incurred by the practice, except physician compensation); and |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Our additional fees which represent our share of the net income of the center (which varies from 10% to 20% or a fixed amount depending on the underlying center, subject to limits in some circumstances). |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                                              |   | For the three-month periodEnded March 31, |   |
|---------------------------------------------------|--------|-------------------------------------------|--------|
|                                              |   | 2010                                      |   |   | 2009 |   |
|                                              |   | (unaudited)                               |   |
|                                              |   | Providers                                 |   |   | Providers |   |
| Partner Fertility Center Financials               |   |                                      |   |   |   |   |
| (a) Patient revenue                               |   | $                                         | 51,959 |   |   | $ | 48,405 |   |
| (b) Cost of services                              |   |                                      | 34,095 |   |   |   | 32,829 |   |
| (c) Base service fee                              |   |                                      | 2,682  |   |   |   | 2,278 |   |
| (d) Practice contribution (a-b-c)                 |   |                                      | 15,182 |   |   |   | 13,298 |   |
| (e) Physician compensation                        |   |                                      | 13,693 |   |   |   | 11,885 |   |
| (f) IntegraMed additional fee                     |   |                                      | 1,489  |   |   |   | 1,474 |   |
|                                              |   |                                      |   |   |   |   |   |   |
| IntegraMed Financials                             |   |                                      |   |   |   |   |   |   |
| (g) IntegraMed gross revenue (b+c+f)              |   |                                      | 38,266 |   |   |   | 36,581 |   |
| (h) Amortization of business service rights       |   |                                      | (324   | ) |   |   | (324 | ) |
| (i) Other revenue                                 |   |                                      | 15     |   |   |   | 26 |   |
| (j) IntegraMed fertility services revenue (g+h+i) |   | $                                         | 37,957 |   |   | $ | 36,283 |   |

|                           |   |   | Q1 2010 |   |   |   | Q1 2009 |   |   | Change |   |   | % Change |   |
|--------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|--------|--------|----------|--------|
| Revenues (000’s)         |   |   | 37,957  |   |   |   | 36,283  |   |   |   | 1,674  |   |     |   | 4.6 | % |
| Operating Income (000’s) |   |   | 3,055   |   |   |   | 2,640   |   |   |   | 415    |   |     |   | 15.7 | % |
| New Patient Visits             |   |   | 7,041   |   |   |   | 6,980   |   |   |   | 61     |   |     |   | .9 | % |
| IVF Cycles                     |   |   | 3,413   |   |   |   | 3,624   |   |   |   | (211   | )      |     |   | (5.8 | %) |

----

| ·   | The number of patients enrolled and receiving treatment |
|--------------------|---------------------------------------------------------|

| ·   | Clinical pregnancy rates |
|--------------------|--------------------------|

|                           |   |   | Q1 2010 |   |   |   | Q1 2009 |   |   | Change |   |   | % Change |   |
|--------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|--------|--------|----------|--------|
| Revenue (000’s)s         |   |   | 6,086   |   |   |   | 5,226   |   |   |   | 860    |   |     |   | 16.5 | % |
| Operating Income (000’s) |   |   | 1,390   |   |   |   | 1,513   |   |   |   | (123   | )      |     |   | (8.1 | %) |
| Enrollments                    |   |   | 361     |   |   |   | 253     |   |   |   | 108    |   |     |   | 42.7 | % |
| Pregnancies                    |   |   | 219     |   |   |   | 211     |   |   |   | 8      |   |     |   | 3.8 | % |

|                           |   |   | Q1 2010 |   |   |   | Q1 2009 |   |   | Change |   |   | % Change |   |
|--------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|--------|--------|----------|--------|
| Revenues (000’s)         |   |   | 12,981  |   |   |   | 10,846  |   |   |   | 2,135  |   |     |   | 19.7 | % |
| Operating Income (000’s) |   |   | 867     |   |   |   | 754     |   |   |   | 113    |   |     |   | 15.0 | % |
| First Leg Starts               |   |   | 1,882   |   |   |   | 1,574   |   |   |   | 308    |   |     |   | 19.6 | % |
| New Consultations              |   |   | 3,420   |   |   |   | 3,121   |   |   |   | 299    |   |     |   | 9.6 | % |

----

----

----

|                                             |   | Payments due by period (000’s omitted) |   |
|--------------------------------------------------|--------|----------------------------------------------|--------|
|                                             |   | Total                                        |   |   | Less than 1 Year |   |   | 1-3 Years |   |   | 4-5 Years |   |   | After 5 Years |   |
|                                             |   |                                         |   |
| Notes payable                                    |   | $                                            | 17,451 |   |   | $ | 3,709 |   |   | $ | 13,742 |   |   | $ | — |   |   | $ | — |   |
| Line of credit outstanding                       |   |                                         | 7,500  |   |   |   | 7,500 |   |   |   | — |   |   |   | — |   |   |   | — |   |
| Capital lease obligations                        |   |                                         | 196    |   |   |   | 90 |   |   |   | 106 |   |   |   | — |   |   |   | — |   |
| Interest on debt                                 |   |                                         | 1,943  |   |   |   | 1,091 |   |   |   | 852 |   |   |   | — |   |   |   |   |   |
| Operating leases                                 |   |                                         | 67,076 |   |   |   | 7,827 |   |   |   | 30,438 |   |   |   | 7,108 |   |   |   | 21,703 |   |
| Fertility Partners capital and other obligations |   |                                         | 1,347  |   |   |   | 1,347 |   |   |   | — |   |   |   | — |   |   |   | — |   |
| Total contractual cash obligations               |   | $                                            | 95,513 |   |   | $ | 21,564 |   |   | $ | 45,138 |   |   | $ | 7,108 |   |   | $ | 21,703 |   |

|                   |   | Amount of Commitment Expiration per Period(000’s omitted) |   |
|------------------------|--------|-----------------------------------------------------------------|--------|
|                   |   | Total                                                           |   |   | Less than 1 Year |   |   | 1-3 Years |   |   | 4-5 Years |   |   | After 5 Years |   |
|                   |   |                                                            |   |
| Unused lines of credit |   | $                                                               | 2,500  |   |   | $ | — |   |   | $ | 2,500 |   |   | $ | — |   |   | $ | — |   |

----

| ·   | We provide a cash credit to the practice for billings to patients and insurance companies;. |
|--------------------|---------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for clinic expenses that we have incurred on behalf of the practice; |
|--------------------|------------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for the base portion of our Service Fee which relates to the Partner revenues; |
|--------------------|----------------------------------------------------------------------------------------------------------|

| ·   | We reduce the cash credit for the variable portion of our Service Fee which relates to the Partner earnings; |
|--------------------|--------------------------------------------------------------------------------------------------------------|

| ·   | We disburse to the medical practice the remaining cash amount which represents the physician's undistributed earnings. |
|--------------------|------------------------------------------------------------------------------------------------------------------------|

| (a)   | Evaluation of disclosure controls and procedures |
|-----------------|--------------------------------------------------|

----

----

|    |   |                                                         |
|---------|--------|--------------------------------------------------------------|
| Item 2. |   | Unregistered Sales of Equity Securities and Use of Proceeds. |
|    |   |  None.                                                  |
|    |   |                                                         |
| Item 3. |   | Defaults upon Senior Securities.                             |
|    |   |                                                         |
|    |   |  None.                                                  |
|    |   |                                                         |
| Item 4. |   | Submission of Matters to Vote of Security Holders       |
|    |   | None.                                                        |

|    |   |                              |
|---------|--------|-----------------------------------|
| Item 5. |   | Other Information                 |
|    |   |                              |
|    |   | None.                             |
|    |   |                              |
| Item 6. |   | Exhibits                          |
|    |   |                              |
|    |   | See Index to Exhibits on Page 27. |
|    |   |                              |

----

|        |        |   |   |                                                                                                              |
|-------------|-------------|--------|--------|-------------------------------------------------------------------------------------------------------------------|
|  Date: | May 7, 2010 |   | By:    | INTEGRAMED AMERICA, INC.(Registrant)  /s/John W. Hlywak, Jr.                                            |
|        |        |   |   | John W. Hlywak, Jr.Executive Vice President andChief Financial Officer(Principal Financial andAccounting Officer) |

----

| ExhibitNumber | Description                                                                                                                                |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------|
|          |                                                                                                                                       |
|          |                                                                                                                                       |
| 31.1          | CEO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 7, 2010        |
|          |                                                                                                                                       |
| 31.2          | CFO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 7, 2010        |
|          |                                                                                                                                       |
| 32.1          | CEO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 7, 2010 |
|          |                                                                                                                                       |
| 32.2          | CFO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 7, 2010 |